Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 683.00 | 799.25 | 0.8546 | 0.6939 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 812.00 | 799.25 | 1.0160 | 1.0337 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 625.00 | 414.82 | 339.00 | 799.25 | 0.4242 | -0.1921 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 919.00 | 799.25 | 1.1498 | 1.3180 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1559.00 | 1981.25 | 0.7869 | 0.6521 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 1803.00 | 1981.25 | 0.9100 | 0.8552 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 830.55 | 797.00 | 1981.25 | 0.4023 | -0.0323 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 1250.00 | 830.55 | 1346.00 | 1981.25 | 0.6794 | 0.4695 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 1250.00 | 830.55 | 1903.00 | 1981.25 | 0.9605 | 0.9368 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 1269.00 | 1981.25 | 0.6405 | 0.4021 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 1250.00 | 830.55 | 1776.00 | 1981.25 | 0.8964 | 0.8330 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 1250.00 | 830.55 | 2184.00 | 1981.25 | 1.1023 | 1.1615 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2197.00 | 1981.25 | 1.1089 | 1.1718 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 1250.00 | 830.55 | 1760.00 | 1981.25 | 0.8883 | 0.8198 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 830.55 | 2164.00 | 1981.25 | 1.0922 | 1.1458 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 830.55 | 780.00 | 1981.25 | 0.3937 | -0.0488 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 1250.00 | 830.55 | 2201.00 | 1981.25 | 1.1109 | 1.1750 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2404.00 | 1981.25 | 1.2134 | 1.3334 | |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 1250.00 | 830.55 | 2108.00 | 1981.25 | 1.0640 | 1.1014 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 1250.00 | 830.55 | 910.00 | 1981.25 | 0.4593 | 0.0756 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 1250.00 | 830.55 | 2079.00 | 1981.25 | 1.0493 | 1.0783 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 1250.00 | 830.55 | 611.00 | 1981.25 | 0.3084 | -0.2171 |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 1938.00 | 1981.25 | 0.9782 | 0.9651 | |
| SK-BR-3 | 0 | uM | 9 | 1250.00 | 830.55 | 2048.00 | 1981.25 | 1.0337 | 1.0535 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 830.55 | 1919.00 | 1981.25 | 0.9686 | 0.9497 |